[{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"4f3d32b3e0558d8315a1e1669defd030d982a10d24d11f147c8b809ffb7f37fd","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[\"n1\",\"n2\",\"n3\",\"n4\"],\"condition\":null,\"course\":null,\"evidence\":\"PHM SCI 751,757,762, or763\",\"id\":\"n0\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":751,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 751\",\"id\":\"n1\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":757,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"757\",\"id\":\"n2\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":762,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"762\",\"id\":\"n3\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":763,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"763\",\"id\":\"n4\",\"kind\":\"course\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"4f3d32b3e0558d8315a1e1669defd030d982a10d24d11f147c8b809ffb7f37fd","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 751\",\"field\":\"description\",\"quote\":\"Identifies and examines the key regulatory agencies and practices that govern the highly regulated and diverse pharmaceutical industry.\"}],\"text\":\"Regulatory frameworks and agency interactions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Scientific process of drug development from discovery through clinical trials.\"}],\"text\":\"End-to-end drug development lifecycle\"},{\"evidence\":[{\"course_id\":\"PHMSCI 762\",\"field\":\"description\",\"quote\":\"Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies\"}],\"text\":\"Preclinical discovery and CMC processes\"},{\"evidence\":[{\"course_id\":\"PHMSCI 763\",\"field\":\"description\",\"quote\":\"Overview of the drug development process from first-in-human (FIH) to submission of a new drug application (NDA) or biologics license application (BLA).\"}],\"text\":\"Clinical development and regulatory submission\"}],\"search_phrases\":[\"drug development case studies\",\"pharmaceutical regulatory strategy\",\"AI in drug discovery\",\"advanced delivery technologies\",\"interdisciplinary drug challenges\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"solving complex and interdisciplinary challenges across the entire development pipeline\"}],\"text\":\"Solving complex interdisciplinary challenges\"},{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"incorporating emerging technologies such as artificial intelligence and advanced delivery technologies\"}],\"text\":\"Incorporating emerging technologies (AI, delivery systems)\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"title\",\"quote\":\"CASE STUDIES IN DRUG DEVELOPMENT\"},{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"Explores the scientific, regulatory, and strategic considerations involved in modern drug development through case studies and real-world scenarios.\"}],\"text\":\"PHMSCI 764 explores scientific, regulatory, and strategic considerations in modern drug development through case studies, emphasizing interdisciplinary problem-solving and emerging technologies.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"scientific, regulatory, and strategic considerations\"}],\"text\":\"Scientific, regulatory, and strategic considerations\"},{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"entire development pipeline\"}],\"text\":\"Entire drug development pipeline\"},{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"artificial intelligence and advanced delivery technologies\"}],\"text\":\"Artificial intelligence and advanced delivery technologies\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"4f3d32b3e0558d8315a1e1669defd030d982a10d24d11f147c8b809ffb7f37fd","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"6fb72cfc42f6803e666cc1545065686250ba9d5fc8a7a397b5d0ceeca4189a45","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[\"n1\",\"n2\",\"n3\",\"n4\"],\"condition\":null,\"course\":null,\"evidence\":\"PHM SCI 751,757,762, or763\",\"id\":\"n0\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":751,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 751\",\"id\":\"n1\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":757,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"757\",\"id\":\"n2\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":762,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"762\",\"id\":\"n3\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":763,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"763\",\"id\":\"n4\",\"kind\":\"course\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"6fb72cfc42f6803e666cc1545065686250ba9d5fc8a7a397b5d0ceeca4189a45","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 751\",\"field\":\"description\",\"quote\":\"Identifies and examines the key regulatory agencies and practices that govern the highly regulated and diverse pharmaceutical industry.\"}],\"text\":\"Regulatory frameworks and agency interactions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Scientific process of drug development from discovery through clinical trials.\"}],\"text\":\"End-to-end drug development lifecycle\"},{\"evidence\":[{\"course_id\":\"PHMSCI 762\",\"field\":\"description\",\"quote\":\"Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies\"}],\"text\":\"Preclinical discovery and CMC processes\"},{\"evidence\":[{\"course_id\":\"PHMSCI 763\",\"field\":\"description\",\"quote\":\"Overview of the drug development process from first-in-human (FIH) to submission of a new drug application (NDA) or biologics license application (BLA).\"}],\"text\":\"Clinical development and regulatory submission\"}],\"search_phrases\":[\"drug development case studies\",\"pharmaceutical regulatory strategy\",\"AI in drug discovery\",\"advanced delivery technologies\",\"interdisciplinary drug challenges\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"solving complex and interdisciplinary challenges across the entire development pipeline\"}],\"text\":\"Solving complex interdisciplinary challenges\"},{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"incorporating emerging technologies such as artificial intelligence and advanced delivery technologies\"}],\"text\":\"Incorporating emerging technologies (AI, delivery systems)\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"title\",\"quote\":\"CASE STUDIES IN DRUG DEVELOPMENT\"},{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"Explores the scientific, regulatory, and strategic considerations involved in modern drug development through case studies and real-world scenarios.\"}],\"text\":\"PHMSCI 764 explores scientific, regulatory, and strategic considerations in modern drug development through case studies, emphasizing interdisciplinary problem-solving and emerging technologies.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"scientific, regulatory, and strategic considerations\"}],\"text\":\"Scientific, regulatory, and strategic considerations\"},{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"entire development pipeline\"}],\"text\":\"Entire drug development pipeline\"},{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"artificial intelligence and advanced delivery technologies\"}],\"text\":\"Artificial intelligence and advanced delivery technologies\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"6fb72cfc42f6803e666cc1545065686250ba9d5fc8a7a397b5d0ceeca4189a45","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"70ef6270864319b54f80a4f9cfc51f7a8e0d18423f04e56c4fc679fdb5eea2f7","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[\"n1\",\"n2\",\"n3\",\"n4\"],\"condition\":null,\"course\":null,\"evidence\":\"PHM SCI 751,757,762, or763\",\"id\":\"n0\",\"kind\":\"any\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":751,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 751\",\"id\":\"n1\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":757,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"757\",\"id\":\"n2\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":762,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"762\",\"id\":\"n3\",\"kind\":\"course\"},{\"children\":[],\"condition\":null,\"course\":{\"course_number\":763,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"763\",\"id\":\"n4\",\"kind\":\"course\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"70ef6270864319b54f80a4f9cfc51f7a8e0d18423f04e56c4fc679fdb5eea2f7","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 751\",\"field\":\"description\",\"quote\":\"Identifies and examines the key regulatory agencies and practices that govern the highly regulated and diverse pharmaceutical industry.\"}],\"text\":\"Regulatory frameworks and agency interactions\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Scientific process of drug development from discovery through clinical trials.\"}],\"text\":\"End-to-end drug development lifecycle\"},{\"evidence\":[{\"course_id\":\"PHMSCI 762\",\"field\":\"description\",\"quote\":\"Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies\"}],\"text\":\"Preclinical discovery and CMC processes\"},{\"evidence\":[{\"course_id\":\"PHMSCI 763\",\"field\":\"description\",\"quote\":\"Overview of the drug development process from first-in-human (FIH) to submission of a new drug application (NDA) or biologics license application (BLA).\"}],\"text\":\"Clinical development and regulatory submission\"}],\"search_phrases\":[\"drug development case studies\",\"pharmaceutical regulatory strategy\",\"AI in drug discovery\",\"advanced delivery technologies\",\"interdisciplinary drug challenges\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"solving complex and interdisciplinary challenges across the entire development pipeline\"}],\"text\":\"Solving complex interdisciplinary challenges\"},{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"incorporating emerging technologies such as artificial intelligence and advanced delivery technologies\"}],\"text\":\"Incorporating emerging technologies (AI, delivery systems)\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"title\",\"quote\":\"CASE STUDIES IN DRUG DEVELOPMENT\"},{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"Explores the scientific, regulatory, and strategic considerations involved in modern drug development through case studies and real-world scenarios.\"}],\"text\":\"PHMSCI 764 explores scientific, regulatory, and strategic considerations in modern drug development through case studies, emphasizing interdisciplinary problem-solving and emerging technologies.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"scientific, regulatory, and strategic considerations\"}],\"text\":\"Scientific, regulatory, and strategic considerations\"},{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"entire development pipeline\"}],\"text\":\"Entire drug development pipeline\"},{\"evidence\":[{\"course_id\":\"PHMSCI 764\",\"field\":\"description\",\"quote\":\"artificial intelligence and advanced delivery technologies\"}],\"text\":\"Artificial intelligence and advanced delivery technologies\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"70ef6270864319b54f80a4f9cfc51f7a8e0d18423f04e56c4fc679fdb5eea2f7","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_a09180e9744638bfd8d7cfdb","course_id":"PHMSCI 764","catalog_version_id":"d142615ac7cc95dfb470f3c021abda9f6681563358d23f1fb38da2cf87e8d8e2","record_version_id":"f705b3d47acee8f51bbf3307fc260db2947ba1097fcb263ef61d8ba118b88b62","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"70ef6270864319b54f80a4f9cfc51f7a8e0d18423f04e56c4fc679fdb5eea2f7","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"895276058f735bd881e2ab4fe724132a50143196ccbd1fb9346ead3a24d276d3\",\"course_id\":\"PHMSCI 764\",\"current_instructors\":[{\"instructor_uid\":\"instructor_3aea62525aeb86c5fbe4025b\",\"message\":\"No course-specific reviews available\",\"name\":\"Leslie Dickmann\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[]}],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":true,\"profile_hash\":\"5cb4dabf887cdbcd8c00d5a1312e10828b95c63f30bc3ea76aea199565390d02\",\"quick_take\":[],\"student_experience\":[],\"task_hash\":\"74fb0997943e888960bbc9e47db8c4fd12e4292d55c20509d8d89db6a9910f68\",\"teaching_history\":[],\"term_id\":\"1272\",\"term_name\":\"2026 Fall\",\"version\":2}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true}]